High-dose methotrexate for elderly patients with newly diagnosed primary central nervous system lymphoma

被引：0
|
作者：
Zhu, J
Mrugala, M
Nugent, W
Hochberg, F
Batchelor, T
机构：
[1] Massachusetts Gen Hosp, Stephen F & Catherine Pappas Ctr Neurooncol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
296
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients
    Guo, Yixian
    Lan, Xiaoxi
    Chang, Xiaoli
    Wang, Guoxiang
    Zou, Dongmei
    Su, Li
    Sun, Wanling
    [J]. BLOOD, 2021, 138
  • [2] High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
    Jahnke, K
    Korfel, A
    Martus, P
    Weller, M
    Herrlinger, U
    Schmittel, A
    Fischer, L
    Thiel, E
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (03) : 445 - 449
  • [3] PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA FOLLOWING TREATMENT WITH HIGH-DOSE METHOTREXATE
    Cappelli, Louis
    Newman, Jennifer
    Sharif, Muhammad
    Kayne, Allison
    Epperla, Narendranath
    Elguindy, Ahmed
    Palmer, Joshua
    Alnahhas, Iyad
    Shi, Wenyin
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [4] High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma
    Gerard, Lauren M.
    Imrie, Kevin R.
    Mangel, Joy
    Buckstein, Rena
    Doherty, Mary
    Mackenzie, Robert
    Cheung, Matthew C.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1882 - 1890
  • [5] Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
    Yuan, Xianggui
    Yu, Teng
    Huang, Yurong
    Jiang, Huawei
    Xu, Xiaohua
    Liang, Yun
    Qian, Wenbin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01):
  • [6] Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
    Xianggui Yuan
    Teng Yu
    Yurong Huang
    Huawei Jiang
    Xiaohua Xu
    Yun Liang
    Wenbin Qian
    [J]. Scientific Reports, 12 (1)
  • [7] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [8] High-dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15-year multicenter experience
    Yoon, Wan-Soo
    Park, Jae-Sung
    Kim, Young-il
    Chung, Dong-Sup
    Jeun, Sin-Soo
    Hong, Yong-Kil
    Yang, Seung Ho
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (01) : 123 - 130
  • [9] Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate
    Warnick, Elizabeth
    Auger, Danielle
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (02) : 177 - 180
  • [10] Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma
    Mei, Shenghui
    Li, Xingang
    Jiang, Xueyun
    Yu, Kefu
    Lin, Song
    Zhao, Zhigang
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (05) : 1454 - 1460
12345